ARK Genomic Revolution ETF ( $ARKG) Rises +12% in 30 Days on Genomics Momentum (See the latest news for any ticker on Tickeron.) ARKG gained roughly +12% over the trailing 30 days, extending a broader multi-month rebound in genomics and healthcare-innovation equities. Over the last quarter, the fund climbed approximately +26%, reflecting renewed demand for high-growth biotechnology and precision-medicine names. The advance was concentrated in core positions spanning gene editing, DNA sequencing, molecular diagnostics, and AI-driven drug discovery. $XBI $IHI $VHT $IXJ
published
ARK Genomic Revolution ETF ( $ARKG) Rises +12% in 30 Days on Genomics Momentum (See the latest news for any ticker on Tickeron.) ARKG gained roughly +12% over the trailing 30 days, extending a broader multi-month rebound in genomics and healthcare-innovation e
$ARKG$XBI$IHI$VHT$IXJ
Latest documented BWB result
$ASML market result
Exit $ASML with $5 profit per contract on the CDS
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.